[Farm93]

I don’t think it’s newsworthy.  Any more than it is newsworthy when someone has a reaction to vacinne X. It’s newsworthy if there are numerous reactions.  Not one.

The UK had two allergic reactions in that first couple of days.  That became global news that was covered widely on USA cable news networks.  It was also discussed during the different groups in the FDA & CDC.

There will always be a first one.  The key is to acknowledge it, but not panic.   I don't think the NYT coverage ventures anywhere close to panic-ville.

Same is true for most pharmaceuticals, medical devices and novel surgical procedures.  Stuff happens and MAY even reveal an important trend that could reveal a key misstep in distribution logistics, local storage or staff administration.   Eventually many things will happen a few times if the vaccines are provided to billions.     Communicating about those hopefully isolated hiccups and potentially learning from them are all part of the process.  

A reporter responsible for covering medical news should look for new work if they fail to cover or feel it is not their job to cover the various firsts that emerge during this process.

NYT - All the news that's fit to print.   IMHO - An allergic reaction in the first week of distribution is fit to print as long as it actually happened.

[Farm93]

I don’t think it’s newsworthy.  Any more than it is newsworthy when someone has a reaction to vacinne X. It’s newsworthy if there are numerous reactions.  Not one.

The UK had two allergic reactions in that first couple of days.  That became global news that was covered widely on USA cable news networks.  It was also discussed during the different groups in the FDA & CDC.

There will always be a first one.  The key is to acknowledge it, but not panic.   I don't think the NYT coverage ventures anywhere close to panic-ville.

Same is true for most pharmaceuticals, medical devices and novel surgical procedures.  Stuff happens and MAY even reveal an important trend that could reveal a key misstep in distribution logistics, local storage or staff administration.   Eventually many things will happen a few times if the vaccines are provided to billions.     Communicating about those hopefully isolated hiccups and potentially learning from them are all part of the process.  

A reporter responsible for covering medical news should look for new work if they fail to cover or feel it is not their job to cover the various firsts that emerge during this process.

NYT - All the news that's fit to print.   IMHO - An allergic reaction in the first week of distribution is fit to print as long as it actually happened.